GlassScriptPhysician profile
Jodene B Shwer
NPI 1619330941
$3,781.16
in general payments reported to CMS, 2019-2025
19 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $21.45 · 2021: $140 · 2022: $393 · 2023: $343 · 2024: $1,030 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,091.17 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Stryker Corporation | $493.35 | 2023-2025 | Infinity, Infinity Adaptis, Citrefix |
| Novo Nordisk INC | $340.32 | 2022-2023 | |
| Integra Lifesciences Corporation | $319.69 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $264.44 | 2021-2022 | |
| Medical Device Business Services, INC. | $261.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.53 | 2023-2024 | Jardiance |
| Treace Medical Concepts, INC. | $151.61 | 2024-2025 | |
| Smith+Nephew, INC. | $124.69 | 2019 | |
| Pfizer INC. | $116.12 | 2019 | |
| Derma Sciences, INC. | $102.31 | 2019 | |
| Osteomed LLC | $97.19 | 2019 | |
| Merck Sharp & Dohme LLC | $40.35 | 2023-2025 | Verquvo, Pifeltro, Capvaxive |
| Novastep INC. | $39.13 | 2022 | |
| Next Science LLC | $36.34 | 2023 | Surgx, Xperience, Blastx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $33.21 | 2023-2024 | Ultomiris |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.45 | 2020 | |
| Depuy Synthes Sales INC. | $18.27 | 2023 | Hammerlock |
| Janssen Pharmaceuticals, INC | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodene Shwer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.